dolasetron
Sign in to saveDolasetron (trade name Anzemet) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata. It does not have much antiemetic effect when symptoms are due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors.
Research
313 papers- Dolasetron.2006
- Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery.Drugs · 1997
- Dolasetron overdose resulting in prolonged QTc interval and severe hypotension: a case report and literature review.Emergency medicine journal : EMJ · 2007
- Dolasetron: a new option for nausea and vomiting.Journal of the American Animal Hospital Association · 2000
- Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.The Cochrane database of systematic reviews · 2020
via PubMed
~4 min read
Encyclopedic overview
5 sectionsContents
- Medical uses
- Adverse effects
- See also
- References
- Further reading
Dolasetron (trade name Anzemet) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata. It does not have much antiemetic effect when symptoms are due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors.
Dolasetron breaks down slowly, staying in the body for a long time. One dose is usually administered once or twice daily and lasts 4 to 9 hours. This drug is removed from the body by the liver and kidneys.
Excerpted from Wikipedia’s “dolasetron” article, available under the CC BY-SA 4.0 licence.
Available in 18 languages
- Español
- Français
- Deutsch
- 中文
- Русский
- Português
- العربية
- Bahasa Indonesia
- Nederlands
- Odia
- Romanian
- Serbian
- Serbian (Latin)
- Tiếng Việt
- Türkçe
- Welsh
- فارسی
via Wikidata sitelinks · CC0